Patients with end-stage renal disease (ESRD) face higher risks of in-hospital mortality and bleeding with transcatheter aortic valve replacement (TAVR) than patients who aren’t dialysis-dependent, researchers report in the Journal of the American College of Cardiology.

Arizona-based R3 Stem Cell, LLC is under fire this week after the FDA sent the company an untitled, three-page letter detailing significant shortcomings in their process.

Despite a sizable financial disadvantage, ST-segment elevation MI (STEMI) patients who could be treated effectively in an intensive or non-intensive care unit fare better in the ICU, according to research published June 4 in The BMJ.

Biotronik is targeting a minimum of 40% female enrollment for its newest project, a large-scale prospective study of sex differences in patients with non-ischemic cardiomyopathy (NICM) and an implanted cardiovascular device.

Heart patients prone to emotionally triggered atrial fibrillation are less likely to experience an arrhythmia if they’re taking beta-blockers, according to a June 3 study published in Heart Rhythm.

New diabetes diagnoses in the U.S. are trending down for the first time in two decades, the CDC has reported, declining 35% since a peak in 2009.

Researchers at Imperial College London have developed a sew-on heart patch that leverages stem cells to support and repair heart muscle after a heart attack—something that could dramatically lower MI survivors’ risk of future heart failure.

Former heart patient Donald Scott gifted Loyola Medicine $1.5 million last week as a thank-you for the care he received there when he suffered an arrhythmia, Loyola announced May 31.